144.01MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
IL0010852080
CUSIP
M25722105
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
0.62
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.16
Wall Street Target Price
5.50
EPS Estimate Current Year
-0.33
EPS Estimate Next Year
-0.33
EPS Estimate Current Quarter
-0.05
EPS Estimate Next Quarter
-0.06
Most Recent Quarter
-
Revenue TTM
27,589,000
Gross Profit TTM
19,361,000
EBITDA
-14,305,500
Profit Margin
-51.27%
Return On Assets TTM
-8.07%
Return On Equity TTM
-24.22%
Revenue Per Share TTM
0.306
Qtly Revenue Growth YOY
-10.70%
Diluted Eps TTM
-0.16
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
0
Price Sales TTM
5.1181
Price Book MRQ
2.5217
Enterprise Value Revenue
1
Enterprise Value EBITDA
-19
556.42
2.00%465.51
1.55%323.65
0.97%293.31
0.45%567.92
0.22%547.60
0.00%161.72
0.00%83.82
0.00%202.16
0.00%101.15
-0.15%